Health Care Cost

In this interview from our Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio, on September 14, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the benefits of value-based care in the breast cancer space.

At the Greater Philadelphia Business Coalition on Health 2023 Wellness Summit, Vikki Walton, MBA, addresses the role employers have in health equity.

Artificial intelligence (AI) tools offer potential solutions to the growing demand in mental health; patients face weight loss drug shortages and insurance complications; updated mask guidelines cause worry among health care workers.

Medicare’s administered pricing system has never had to deal with labor scarcity before.

"Even though awareness was increasing, it wasn't translating into action," Taylor-Desir explains. "We know from our experience as physicians, that physical health and mental health are tied."

While regional variations were identified in rates of breast reconstruction, complications, and cost for patients with breast cancer, these differences did not seem to be associated with any implicit bias.

A report from the Association for Accessible Medicines (AAM) highlighted the value of biosimilars and generics, revealing that lower-cost versions of originator products accumulated $408 billion for the US health care system in 2022.

Lisa Rometty, CEO at Zerigo Health, discusses digital health innovations, strategies, and partnerships to improve the lives of patients living with chronic skin conditions.

A recent CDC study revealed that reports of mistreatment and discrimination during maternity care were high among Black, Hispanic, and multiracial respondents.

Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, discusses treatment options available to patients with rare diseases, as well as the challenges these patients and their pharmacists face in accessing these treatments.

Insomnia, along with other sleep disorders, were found to negatively impact workplace productivity.

Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.

The authors’ multidisciplinary care management program shows promise, as the reduction in per-patient per-month spending was $116. However, these financial benefits took time to materialize.

Drug spending for products facing generic or biosimilar competition decreased during the same time period.

The consortium involved in the newborn genomic sequencing initiative consists of a diverse and growing selection of stakeholders.

The playbook includes resources for purchasers to help in their dealings with pharmacy benefit managers (PBMs), including best practice checklists, sample questionnaires for choosing consultants, and recommendations for contracting language.

An uptick in laxative use causes shortage; ketamine can help suicidal thoughts but can be hard to access; new data suggest that abortions increased in most states in 2023.

Care quality is high in both the United States and Canada, but there are commonalities in regard to drug access and cost issues, particularly with advanced medications, noted G. B. John Mancini, MD, University of British Columbia.

Rising temperatures demand action against heat-related illnesses; school superintendents face complex decisions as COVID-19 cases rise; national staffing standards for nursing homes present challenges.

Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

While the challenges in affordability and accessibility emphasize the importance of early awareness and interventions, equitable access to the screening itself poses a crucial hindrance.

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.

The Biden administration has released the first 10 drugs subject to price negotiation with Medicare under the Inflation Reduction Act (IRA), and among those chosen were Stelara (ustekinumab) and Enbrel (etanercept), both of which will face biosimilar competition within the next decade.

"We won't be content until this is indeed performed in 98% of babies," Stephen Kingsmore, MD, DSc, explains.

A study highlights an unmet need for patients with acute myeloid leukemia (AML) to access and afford genomic testing, especially among an older patient population.